Chemomab Therapeutics Ltd. is a startup based in Israel, 1 tracked investor.
Based in Israel, Chemomab Therapeutics Ltd. is a startup. Brouky records 1 investor associated with the company.
Chemomab Therapeutics is a clinical stage biotechnology company developing nebokitug, a monoclonal antibody targeting the CCL24 protein to treat fibro-inflammatory diseases such as liver, skin, and lung fibrosis.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.